If a specific GLP-1 drug, such as Ozempic, is causing intolerable side effects, speak with your healthcare provider about trying another antidiabetic or weight loss medication with the same active ingredient, such as Wegovy (weight loss drug), or another medication from the same class of GLP-1 medications, such as Mounjaro, which may be better tolerated
Changes can also reflect shifts in hydration, inflammation, nutrition status, mobility, comorbidities, or concurrent medications
Maintenance planning Clear discussion about how to maintain results if the medication is reduced or discontinued, with emphasis on sustainable habits and metabolic health, not just the number on the scale
The trial team will assess the exposure against the IMP label and protocol and advise whether the medicine remains suitable for use